Evidence map›Paper›PMID 26898110›Full record

ReviewNature reviews. Immunology2016

Mucosal immunity to pathogenic intestinal bacteria.

Araceli Perez-Lopez, Judith Behnsen, Sean-Paul Nuccio, Manuela Raffatellu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 2 syntheses or guidelines pooled it, 358 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The gut-joint axis in osteoarthritis.Nature reviews. Rheumatology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Frontiers in microbiology · 2026
    Article
  19. Review
  20. Review

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Araceli Perez-LopezDepartment of Microbiology and Molecular Genetics, and Institute for Immunology, University of California Irvine School of Medicine, Irvine, California 92697-4025, USA.
Judith BehnsenDepartment of Microbiology and Molecular Genetics, and Institute for Immunology, University of California Irvine School of Medicine, Irvine, California 92697-4025, USA.
Sean-Paul NuccioDepartment of Microbiology and Molecular Genetics, and Institute for Immunology, University of California Irvine School of Medicine, Irvine, California 92697-4025, USA.
Manuela RaffatelluDepartment of Microbiology and Molecular Genetics, and Institute for Immunology, University of California Irvine School of Medicine, Irvine, California 92697-4025, USA.
University of California, Irvine · US

Funding

INTESTINAL VITAMIN H UPTAKE--MOLECULAR/CELL REGULATIONR01DK058057 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI SAID, HAMID M · 2000 to 2019
$6.8M
Mucosal barrier function during Salmonella infectionR01AI083663 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI RAFFATELLU, MANUELA · 2010 to 2014
$1.9M
Development of siderophore-based vaccines against non-typhoidal Salmonella infectionR01AI114625 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NOLAN, ELIZABETH M, RAFFATELLU, MANUELA · 2015 to 2019
$1.9M
The role of the circadian clock during Salmonella infectionR21AI105374 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI RAFFATELLU, MANUELA, SASSONE-CORSI, PAOLO · 2014 to 2015
$424k
Targeting iron acquisition in Salmonella with siderophore-based immunizationR21AI101784 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI NOLAN, ELIZABETH M, RAFFATELLU, MANUELA · 2014 to 2015
$418k
NIAID NIH HHS AI083663NIAID NIH HHS AI101784NIAID NIH HHS AI105374NIAID NIH HHS AI114625NIDDK NIH HHS DK058057
6 · The paper itself

Abstract

The intestinal mucosa is a particularly dynamic environment in which the host constantly interacts with trillions of commensal microorganisms, known as the microbiota, and periodically interacts with pathogens of diverse nature. In this Review, we discuss how mucosal immunity is controlled in response to enteric bacterial pathogens, with a focus on the species that cause morbidity and mortality in humans. We explain how the microbiota can shape the immune response to pathogenic bacteria, and we detail innate and adaptive immune mechanisms that drive protective immunity against these pathogens. The vast diversity of the microbiota, pathogens and immune responses encountered in the intestines precludes discussion of all of the relevant players in this Review. Instead, we aim to provide a representative overview of how the intestinal immune system responds to pathogenic bacteria.

Indexed as

BacteriaHumansImmunity, InnateImmunity, MucosalIntestinal Mucosa

Identifiers

PMID26898110
OpenAlexW2276961144

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.